Targeted
Medical Pharma (OTCQB:TRGM), today announced that William Shell,
M.D., Chairman, CSO and CEO is scheduled to present the latest company
information regarding the advances in therapeutic
nutrition and medical
foods technology, at the 14th Annual Biotech in Europe Forum at the
Congress Center in Basel, Switzerland. The presentation is scheduled for
September 30th, 2014 at 11:45 am in the Lima Room. Dr. Shell
will also be a panelist in the discussion regarding advancements in
Neuroscience at 3:30 pm.
Additional information about the conference may be found at www.sachsforum.com.
Attendees who wish to meet with management one on one may contact our
Investor Relations department: investors@tmedpharma.com
About Targeted Medical Pharma, Inc.
Targeted
Medical Pharma, Inc. (OTCQB: TRGM) is a publicly traded, Los
Angeles-based biotechnology company that is committed to drug discovery
and development. The company currently develops and distributes amino
acid based medical foods, a rapidly growing sector of medication
technology, for the treatment of chronic disease, including pain
syndromes, peripheral neuropathy, hypertension, obesity, sleep and
cognitive disorders using the patented system of Targeted
Cellular Technology.
The company also develops a line of dietary supplements designed to
support health and wellness. TMP currently manufactures 10 proprietary
amino acid based medical
foods, and recently launched its first dietary supplement, Clearwayz™.
The products are sold directly to physicians and pharmacies in the U.S.
The Company is also developing nutrient-based systems for oral
stimulation of progenitor stem cells that differentiate into neurons,
red blood cells, pituitary hormones including IGF-I.
Follow the Company on twitter
@tmedpharma.
Copyright Business Wire 2014